Polyherbal decoction for Psoriatic arthritis

A clinical study to evaluate the effectiveness of Navakarshika kashaya in Vatarakta(Psoriatic arthritis)

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2021/01/030790

Enrollment

Registered

2021-01-27

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L405- Arthropathic psoriasis

Interventions

Intervention1: Navakarshika kashaya: Navakarshika kashaya will be provided in form of powdered raw material for the purpose of making fresh decoction. Decoction thus formed will be given in dose of 30

Eligibility

Inclusion criteria

Inclusion criteria: Subjects having minimum three of the clinical features of Vatarakta as mentioned in Charak Samhita Chikitsa Sthana Vatashonita chikitsa adhyaya ruja(joint pain of varying severity), shvayathu(joint swelling), stabdhta(joint stiffness), shyavata tamrata(discoloration) and having Psoriatic arthritis as diagnosed by CASPAR criteria (Classification Criteria for Psoriatic Arthritis). Subjects who are ready to give consent for trial with firm residential address and contact numbers.

Exclusion criteria

Exclusion criteria: Subjects having no symptoms of Vatarakta as mentioned in Charak Samhita Chikitsa Sthana Vatashonita chikitsa adhyaya and not meeting CASPAR criteria (Classification Criteria for Psoriatic Arthritis). Subjects with known other causes of inflammatory arthritis. Subjects with pre-established co-morbid chronic illness, such as diabetes, hypertension, coronary artery disease and having any other concomitant illness that may affect the study. Pregnant or lactating subjects. Subjects with known hypersensitivity to contents of Navakarshika kashaya. Subjects currently receiving any drug(s) that can influence outcome measures of study, such as DMARDs, NSAIDs, PDE4.

Design outcomes

Primary

Measure	Time frame
Improvement in DAPSA(Disease Activity index for Psoriatic Arthritis) ScoreTimepoint: Day1, Day14, Day28	—

Secondary

Measure	Time frame
Attainment of status of Dhatusamyata and Vikaropshama. Timepoint: Day1, Day14, Day28;Improvement in grade of symptom severity of Vatarakta.Timepoint: Day1, Day14, Day28;Improvement in markers of inflammation (ESR, CRP.)Timepoint: Day1, Day14, Day28	—

Countries

India

Contacts

Public ContactDr Yogesh Kumar Pandey

Chaudhary Brahm Prakash Ayurved Charak Sansthan

mansimannu2910@gmail.com9560462029

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026